Quantitative Methods And Modeling Complex Generics - Sep. 25-26, 2019

Quantitative Methods and Modeling (29of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Quantitative Clinical Pharmacology in LA Injectables (34of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Physiologically-based Pharmacokinetic Modeling (32of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Credibility for Computational Fluid Dynamics Models (33of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Dose-Scale Analysis in Pharmacodynamic Equivalence (31of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

BE Approaches for Long Acting Drug Products (14of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Questions and Answers (4of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Questions and Answers (17of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (28of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Overview of Comparative Analyses - Clinical Perspective (19of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Questions and Answers (22of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Generic Topical and Transdermal Products (5of35) Complex Generics– Sep. 25-26, 2019

U.S. Food and Drug Administration

Questions and Answers (13of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Bioequivalence for Generic Topical and Transdermal (6of35) Complex Generics– Sep. 25-26, 2019

U.S. Food and Drug Administration

Strategies for Generic Topical Product Development (7of35) Complex Generics– Sep. 25-26, 2019

U.S. Food and Drug Administration

Comparative Analyses: Device and User Interface (25of35) Complex Generics– Sep. 25-26, 2019

U.S. Food and Drug Administration

PSG Recommendations and Updates for OINDPs (23of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Complex Peptide ANDAs: Test/Reference Comparability (11of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration

Comparative Analyses: Injectable Combination Products (21of35) Complex Generics – Sep. 25-26, 2019

U.S. Food and Drug Administration